Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay

Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide. Although a number of promising potential vaccines and therapeutic agents for SARS-CoV have been described, no effective antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yanchen, Agudelo, Juliet, Lu, Kai, Goetz, David H., Hansell, Elizabeth, Chen, Yen Ting, Roush, William R., McKerrow, James, Craik, Charles S., Amberg, Sean M., Simmons, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205982/
https://www.ncbi.nlm.nih.gov/pubmed/21820471
http://dx.doi.org/10.1016/j.antiviral.2011.07.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205982/
https://www.ncbi.nlm.nih.gov/pubmed/21820471
http://dx.doi.org/10.1016/j.antiviral.2011.07.016

Ejemplares similares